Wiley Online Library : Helicobacter
51 followers 3 articles/week
Four cases of non‐Helicobacter pylori Helicobacter‐infected gastritis with duodenal spiral bacilli

Abstract Background Non-Helicobacter pylori Helicobacter (NHPH) is rarely detected in duodenal mucosa due to its preference for slightly acidic environments. Here, we report four cases of NHPH-infected gastritis with duodenal spiral bacilli, potentially NHPH, indicating the possibility of duodenal mucosal infection. Case Presentation In every case,...

Sat Apr 27, 2024 16:22
Diagnostic performance of linked color imaging for gastric cancer by Helicobacter pylori infection status: A subanalysis of the large‐scale, multicenter randomized controlled trial LCI‐FIND

Abstract Background Linked color imaging (LCI) is a new image enhancement technology that facilitates the recognition of subtle differences in mucosal color. In the large-scale, multicenter randomized controlled trial LCI-FIND, LCI demonstrated good diagnostic performance for the detection of tumor lesions in the upper gastrointestinal tract. The...

Sat Apr 27, 2024 16:22
The role of microbiota in gastric cancer: A comprehensive review

Abstract Background Gastric cancer (GC) continues to pose a significant global threat in terms of cancer-related fatalities. Despite notable advancements in medical research and therapies, further investigation is warranted to elucidate its underlying etiology and risk factors. Recent times have witnessed an escalated emphasis on comprehending the...

Sun Apr 21, 2024 15:49
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target

Abstract Background The current standard treatment for Helicobacter pylori infection, which involves a combination of two broad-spectrum antibiotics, faces significant challenges due to its detrimental impact on the gut microbiota and the emergence of drug-resistant strains. This underscores the urgent requirement for the development of novel anti-H....

Wed Apr 17, 2024 15:06
A reconstructed genome‐scale metabolic model of Helicobacter pylori for predicting putative drug targets in clarithromycin and rifampicin resistance conditions

Abstract Background Helicobacter pylori is considered a true human pathogen for which rising drug resistance constitutes a drastic concern globally. The present study aimed to reconstruct a genome-scale metabolic model (GSMM) to decipher the metabolic capability of H. pylori strains in response to clarithromycin and rifampicin along with identification...

Mon Apr 15, 2024 14:42
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article

Abstract Background Helicobacter pylori infection and its associated diseases represent a significant global health concern. Patients who cannot use amoxicillin pose a therapeutic challenge and necessitate alternative medications. Preliminary research indicates that cefuroxime demonstrates promising potential for eradicating H. pylori infection, and...

Fri Apr 12, 2024 14:01

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account